EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC 4.0

Effects of the Current Japanese Guideline for Dedicated, Intensive Lipid-lowering Therapy on Lipid Profile and Coronary Events in Patients After Acute Coronary Syndrome

Ryotaro Yamada, Teruyoshi Kume, Hiroshi Okamoto, Masahiro Yamashita, Satoshi Koto, Kyo Kamisaka, Yoshitaka Sasahira, Yasuyuki Sudo, Ayano Enzan, Tomoko Tamada, Terumasa Koyama, Koichiro Imai und 3 weitere

Journal of Asian Pacific Society of Cardiology · 2022

DOI: 10.15420/japsc.2021.21 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Asian Pacific Society of Cardiology, 2022. Verfasst von Ryotaro Yamada und 14 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with acute coronary syndrome (ACS) still have high rates of recurrent adverse cardiovascular events. The purpose of this study was to evaluate the effects of changes in the Japan Atherosclerosis Society Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases for intensive lipid-lowering therapy on the prescription status, lipid profile and clinical outcomes among Japanese patients with ACS.

Methods

Data were retrospectively analysed for 283 consecutive patients with de novo ACS who underwent primary percutaneous coronary intervention and received follow-up coronary angiography between January 2012 and September 2019. Patients were divided into two groups according to the to onset of ACS relative to the guideline update – before (Group 1; n=182) and after (Group 2; n=101). Changes in prescription status, lipid profile and clinical outcomes (composite of cardiac death and non-fatal MI, coronary events from culprit and non-culprit lesions) were evaluated.

Results

Post-treatment LDL concentrations were significantly lower in Group 2, but target LDL concentrations of

Zitieren

APA

Yamada, R., Kume, T., Okamoto, H., Yamashita, M., Koto, S., Kamisaka, K., Sasahira, Y., Sudo, Y., Enzan, A., Tamada, T., Koyama, T., Imai, K., Nishi, T., Neishi, Y., & Uemura, S. (2022). Effects of the Current Japanese Guideline for Dedicated, Intensive Lipid-lowering Therapy on Lipid Profile and Coronary Events in Patients After Acute Coronary Syndrome. Journal of Asian Pacific Society of Cardiology. https://doi.org/10.15420/japsc.2021.21

Vancouver

Yamada R, Kume T, Okamoto H, Yamashita M, Koto S, Kamisaka K, et al. Effects of the Current Japanese Guideline for Dedicated, Intensive Lipid-lowering Therapy on Lipid Profile and Coronary Events in Patients After Acute Coronary Syndrome. Journal of Asian Pacific Society of Cardiology. 2022. doi:10.15420/japsc.2021.21

BibTeX
@article{Yamada2022,
  author = {Yamada, Ryotaro and Kume, Teruyoshi and Okamoto, Hiroshi and Yamashita, Masahiro and Koto, Satoshi and Kamisaka, Kyo and Sasahira, Yoshitaka and Sudo, Yasuyuki and Enzan, Ayano and Tamada, Tomoko and Koyama, Terumasa and Imai, Koichiro and Nishi, Takeshi and Neishi, Yoji and Uemura, Shiro},
  title = {Effects of the Current Japanese Guideline for Dedicated, Intensive Lipid-lowering Therapy on Lipid Profile and Coronary Events in Patients After Acute Coronary Syndrome},
  journal = {Journal of Asian Pacific Society of Cardiology},
  year = {2022},
  doi = {10.15420/japsc.2021.21}
}
Kostenlos starten →